Efficacy and safety of everolimus with reduced tacrolimus in living‐donor liver transplant recipients: 12‐month results of a randomized multicenter study-Reference-Cited by-同舟云学术

Efficacy and safety of everolimus with reduced tacrolimus in living‐donor liver transplant recipients: 12‐month results of a randomized multicenter study

Published:2018-01-25 Issue:6 Volume:18 Page:1435-1446
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Jeng Long‐Bin¹,Lee Sung Gyu²,Soin Arvinder Singh³,Lee Wei‐Chen⁴,Suh Kyung‐Suk⁵,Joo Dong Jin⁶,Uemoto Shinji⁷,Joh Jaewon⁸,Yoshizumi Tomoharu⁹,Yang Horng‐Ren¹,Song Gi‐Won²,Lopez Patricia¹⁰,Kochuparampil Jossy¹⁰,Sips Carole¹⁰,Kaneko Shuhei¹¹,Levy Gary¹²

Affiliation:

1. China Medical University Hospital Taichung Taiwan

2. Asan Medical Center Seoul Republic of Korea

3. Medanta Medicity Hospital Gurgaon India

4. Chang Gung Memorial Hospital Tao‐Yuan Lin‐Ko Taiwan

5. Seoul National University College of Medicine Seoul Republic of Korea

6. Yonsei University College of Medicine Severance Hospital Seoul Republic of Korea

7. Kyoto University Hospital Kyoto Japan

8. Samsung Medical Center Seoul Republic of Korea

9. Kyushu University Hospital Fukuoka‐city Japan

10. Novartis Pharma AG Basel Switzerland

11. Novartis Pharma KK Tokyo Japan